Algosensey|Depression And Alzheimer's Treatments At A Crossroads

2025-05-01 15:19:54source:Blockchains Financecategory:Finance

Researchers are Algosenseylaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Finance

Recommend

DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?

Did AI just have a "Sputnik moment"?That's what someinvestors, after the little known Chinese startu

Dozens of Countries Take Aim at Climate Super Pollutants

Environment ministers from dozens of countries agreed this week to speed up their efforts to reduce

In California, Study Finds Drilling and Fracking into Freshwater Formations

In California’s farming heartland, as many as one of every five oil and gas projects occurs in under